Showing results (11-20 of 146) with videos related to

Sort By:
Pageof 15
Asian Journal of Urology|February 19, 2019
Current strategies for targeting the activity of androgen receptor variantsCameron M Armstrong, Allen C Gao
Endocrine-Related Cancer|September 4, 2014
Zoledronic acid at the time of castration prevented castration-induced bone metastasis in miceParamita M Ghosh, Allen C Gao
The Prostate|October 15, 2009
Microarray analysis reveals potential target genes of NF-kappaB2/p52 in LNCaP prostate cancer cellsNagalakshmi Nadiminty, Smitha Dutt, Clifford Tepper, et al.
Molecular Cancer Therapeutics|July 22, 2017
Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer CellsRamakumar Tummala, Wei Lou, Allen C Gao, et al.
The Journal of Urology|June 11, 2003
Regulation of androgen and vitamin d receptors by 1,25-dihydroxyvitamin D3 in human prostate epithelial and stromal cellsEddy S Leman, Fernando DeMiguel, Allen C Gao, et al.
Translational Andrology and Urology|January 28, 2016
Mechanisms of resistance in castration-resistant prostate cancer (CRPC)Thenappan Chandrasekar, Joy C Yang, Allen C Gao, et al.
BMC Medicine|September 3, 2015
Targeting molecular resistance in castration-resistant prostate cancerThenappan Chandrasekar, Joy C Yang, Allen C Gao, et al.
Oncotarget|April 7, 2016
Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancerChengfei Liu, Cameron Armstrong, Yezi Zhu, et al.
The Prostate|September 11, 2008
NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivationNagalakshmi Nadiminty, Jae Yeon Chun, Wei Lou, et al.
Molecular Cancer Therapeutics|July 16, 2005
Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkersYan Dong, Haitao Zhang, Allen C Gao, et al.
Pageof 15